Noida, UP -- (SBWire) -- 05/05/2015 --According to a new research report by RNCOS entitled, "Global Influenza Vaccine Market Outlook 2020", US dominates the influenza vaccine market in the world and the emerging countries of Asia Pacific region is expected to capture a significant share in the Global Influenza Vaccine Market.
Fluzone is considered to be the most demanded influenza vaccine in the world and the manufacturer Sanofi Pasteur sold its 220 Million doses in the year 2014. The market which stood at US$ 3.2 Billion in 2014 has potential to report a significant growth in next six years.
The market is anticipated to grow at 8% CAGR to become US$ 5 Billion by 2020. Emerging markets such as China and India have been the fastest growing countries. Sanofi Pasteur, GSK, Novartis, CSL and AstraZeneca are top five influenza vaccine companies.
Research Analysis & Highlights
The report is spread in over 85 pages and provides an in-depth research and rational analysis of the current status and future prospect of the Global Influenza Vaccine Industry. The study presents transparent picture major influenza vaccines such as FluMist, Flucelvax, Afluria, Fluzone, Fluarix and Anflu including the factors affecting their growth. The research further covers global influenza vaccine industry, detailed analysis of geographical segments, pipeline analysis, pricing analysis as well as Mergers and Acquisitions.
The report also covers detailed information about active market players in the Global Influenza Vaccine Industry, including small and large players to enable the clients understand the market structure and its growth during the forecasted period. In brief, the report covers all the necessary aspects of the global influenza vaccine industry, providing an in-depth research and prudent analysis of the key segments.
Some of the report's key highlights include:
- Major influenza vaccines such as FluMist, Flucelvax, Afluria, Fluzone, Fluarix and Anflu and their growth
- Geographical Segmentation- Europe, US, Emerging Countries and Rest of the World
- Mergers and Acquisition followed by premium deals during the year 2014
- Leading Players and their share in global influenza vaccine industry
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM743.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
About RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.
Global Influenza Vaccine Industry to Witness Astounding Growth in Six Years
“Introduction of new vaccines, increasing healthcare expenditure, etc will drive the global influenza vaccine market to become US$ 5 Billion by 2020”, says RNCOS.